ロード中...
In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. In this study, sorafenib-loaded lipid-based nanosuspensions (sorafenib-LNS) were first developed as an intravenous injectable formulation to increase the efficacy of sorafenib against HCC. LNS were used as nanocarri...
保存先:
| 出版年: | Int J Nanomedicine |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4887074/ https://ncbi.nlm.nih.gov/pubmed/27307733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S104119 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|